Join in the mischief!
Get ready to outsmart OA with Galli-Play. Help Dot get hold of Galliprant and catch her favourite things, while avoiding those naughty items she knows she shouldn’t touch!
Register your score for the chance to win!*
Once your score is registered, you will be entered into a prize draw where three lucky winners will get their cheeky paws on a £100 Amazon Gift Voucher* to spend as they please!
Try Galli-Play
Note: if you see an empty box below, then please navigate to the bottom of the page and click on "Cookie Preferences". To view the game you need to change the Advertising Cookies selection from "No" to "Yes". Press "Submit" and "Close", then reload the page.
Bring back Dot's garden days - with Galliprant™
Thanks to Galliprant, the first and only piprant that precisely targets OA pain1,2, it’s possible to detect and treat OA pain3 at the start of a dog’s OA journey, getting dogs like Dot back to doing what they love.
Hear about why we should be treating OA earlier – a first-opinion vet view on shocking data from a recent prevalence study of OA in young dogs.
DISCOVER ALL THE BENEFITS OF MYELANCO
* See the Terms & Conditions
- Kirkby Shaw K. Introduction to the emerging piprant therapeutic class: prostanoid receptor antagonists. Oral presentation. American College of Veterinary Internal Medicine Forum, 3–6 June 2015, Indianapolis IN, USA.
- Pye C, et al. Advances in the pharmaceutical treatment options for canine osteoarthritis. J Small Anim Pract 2022;63:721–738.
- Wright A, et al. J Small Anim Pract 2022;63:609–618.
